Palo Alto, CA, United States of America

Atul D Ayer

This inventor holds 97 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in Drug Delivery Systems (CPC class 424473). Top assignees: Alza Corporation, Mcneil-Ppc, Inc., Alza Corporatino. Active years: 1977-2016.

USPTO Granted Patents = 97 

% Patents Active = 96.9

 


Average Co-Inventor Count = 3.1

ph-index = 39

Forward Citations = 6,699(Granted Patents)

Forward Citations (Not Self Cited) = 6,472(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Belmont, CA (US) (1977 - 1978)
  • Mt. View, CA (US) (1979 - 1991)
  • Mountain View, CA (US) (1980 - 1992)
  • Palo Alto, CA (US) (1989 - 2016)

Company Filing History:


Years Active: 1977-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Osmotic Dosage Form
Controlled Delivery
Sustained Therapy
Rapidly Disintegrating Tablets
Antiepileptic Therapy
Phenytoin Therapy
Analgesic Compositions
Anti-Asthma Therapy
Nutritional Support
Drug Administration
Medicinal Tablet
Reboxetine Therapy
97 patents (USPTO):Explore Patents

Title: The Innovative Journey of Atul D Ayer

Introduction: Atul D Ayer is a renowned inventor based in Palo Alto, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Atul D Ayer holds several patents in the areas of technology, healthcare, and sustainability, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Atul D Ayer has worked with leading companies and research institutions, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Atul D Ayer has collaborated with top inventors, patent attorneys, and companies, fostering a culture of creativity and excellence in his projects.

Conclusion: Atul D Ayer's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…